Related Experiment Video

Updated: May 20, 2026

Simultaneous Affinity Enrichment of Two Post-Translational Modifications for Quantification and Site Localization
12:11

Simultaneous Affinity Enrichment of Two Post-Translational Modifications for Quantification and Site Localization

Published on: February 27, 2020

Serendipity of post-hoc surrogate marker research

Fleurtje M van der Valk, Diederik F van Wijk, Erik S G Stroes

    European Heart Journal
    |July 10, 2012
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
    05:53

    Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

    Published on: June 21, 2018

    Related Experiment Videos

    Last Updated: May 20, 2026

    Simultaneous Affinity Enrichment of Two Post-Translational Modifications for Quantification and Site Localization
    12:11

    Simultaneous Affinity Enrichment of Two Post-Translational Modifications for Quantification and Site Localization

    Published on: February 27, 2020

    Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
    05:53

    Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

    Published on: June 21, 2018

    Related Concept Videos

    Genome-wide Association Studies-GWAS01:11

    Genome-wide Association Studies-GWAS

    Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
    GWAS does not require the identification of the target gene involved in...
    Pharmacogenomics: Identification of New Drug Targets01:29

    Pharmacogenomics: Identification of New Drug Targets

    Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...

    Articles linked to this work by shared authors, journal, and citation graph.

    Aortic valve stenosis in 2026: from emerging mechanisms to clinical drug development.

    Atherosclerosis·2026

    Associations of VICTORION-1 PREVENT eligibility with subclinical cardiovascular and inflammatory damage in a European population-based cohort.

    American journal of preventive cardiology·2026

    Combined LDL-C, Lp(a), and hsCRP Assessment Predicts ASCVD in the Multiethnic HELIUS Cohort.

    Journal of the American College of Cardiology·2026

    Safety of low lipoprotein(a) levels: the FOURIER trial.

    European heart journal·2026

    The impact of lipoprotein(a) on coronary atherosclerotic plaque phenotype in primary prevention.

    European journal of preventive cardiology·2026

    Reduced postprandial lipid accumulation in circulating monocytes by olezarsen attenuates pro-inflammatory changes in hypertriglyceridemic patients.

    European heart journal open·2026

    Heart transplantation allograft survival: donor atherosclerotic disease risk vs coronary angiography.

    European heart journal·2026

    Finerenone benefits in patients with cardio-kidney-metabolic syndrome with or without history of cancer: the FINE-HEART pooled analysis.

    European heart journal·2026

    Immunological risk identified by single-cell multi-omics and cardiovascular outcomes.

    European heart journal·2026

    Gender-related risk of myocardial infarction and subclinical coronary atherosclerosis: a Danish population cohort study.

    European heart journal·2026

    Oral anticoagulants, cognition, and clinical outcomes in atrial fibrillation and Alzheimer's disease: a Swedish nationwide study.

    European heart journal·2026

    Role of Social Determinants of Health in Risk Prediction Models for ST-Segment-Elevation Myocardial Infarction Death: A Registry-Based Study.

    Journal of the American Heart Association·2026

    Impact of social deprivation on cancer occurrence and cardiovascular events in systemic sclerosis.

    Rheumatology advances in practice·2026

    Current Practices and Perspectives on Video Capsule Endoscopy in Germany: Findings from a nationwide survey of gastroenterologists.

    Zeitschrift fur Gastroenterologie·2026

    Neighborhood Socioeconomic Status and Heart Failure or All-Cause Readmission Within a Municipal Hospital System.

    JACC. Advances·2026

    The association between social determinants of health and Parkinson's disease prevalence among U.S. adults: A cross-sectional study.

    Parkinsonism & related disorders·2026

    Immigrant life expectancy and disability-free life expectancy by detailed country of birth in England and Wales: A total population, repeated cross-sectional approach.

    PloS one·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us